Top Markets
Coin of the day
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
Rangering i aksjer #40630
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
Aksjekurs
$0.00045794
Sist synkronisert: 2025-07-11
Markedsverdi
$107.51K
Endring (1 dag)
-36.01%
Endring (1 år)
0.00%
Land
DK
Handel Scandion Oncology A/S (SCOL)

Kategori

Pris SCOL pris med markedsverdi på B
Scandion Oncology A/S Scandion Oncology A/S
SCOL
$0.00045794
Markedsverdi av Scandion Oncology A/S(SCOL)
Markedsverdi: $107.51K
Per August 2026 har Scandion Oncology A/S en markedsverdi på $107.51K. Dette gjør Scandion Oncology A/S til det 40630th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Scandion Oncology A/S fra 2018 til 2026
SCOL sammenlignet med topp 5 mest populære stocks
Pris på SCOL Eiendel B Markedsverdi for B Resultater
Scandion Oncology A/S Scandion Oncology A/S
$23,282.01 $107.51K
$5.466T +5,084,036,456.11%
Scandion Oncology A/S Scandion Oncology A/S
$18,981.00 $107.51K
$4.456T +4,144,833,379.17%
Scandion Oncology A/S Scandion Oncology A/S
$17,773.68 $107.51K
$4.173T +3,881,194,482.81%
Scandion Oncology A/S Scandion Oncology A/S
$15,708.46 $107.51K
$3.688T +3,430,218,279.11%
Scandion Oncology A/S Scandion Oncology A/S
$12,202.26 $107.51K
$2.865T +2,664,578,625.41%